Lee W, Sheehan C, Chye R, Chang S, et al. Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study. PLoS One 2023;18:e0290876.
PMID: 37963146